Brokers Issue Forecasts for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - KeyCorp issued their FY2024 earnings per share estimates for shares of Acadia Healthcare in a report issued on Monday, January 6th. KeyCorp analyst M. Gillmor anticipates that the company will post earnings per share of $3.39 for the year. KeyCorp has a "Overweight" rating and a $70.00 price objective on the stock. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare's Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.66 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $3.20 EPS and FY2026 earnings at $3.98 EPS.

A number of other brokerages also recently weighed in on ACHC. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. TD Cowen lowered their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a research note on Monday, November 18th. Finally, Barclays reduced their price target on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research report on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $70.22.

Acadia Healthcare Stock Down 0.0 %

Acadia Healthcare stock traded down $0.01 during mid-day trading on Thursday, reaching $45.12. 2,543,740 shares of the company were exchanged, compared to its average volume of 2,378,388. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The business has a fifty day moving average of $40.48 and a 200 day moving average of $58.19. The firm has a market cap of $4.19 billion, a P/E ratio of 14.79, a PEG ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.91 earnings per share.

Institutional Trading of Acadia Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. GAMMA Investing LLC raised its stake in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare in the 2nd quarter worth approximately $59,000. Covestor Ltd raised its position in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock worth $72,000 after buying an additional 1,018 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in Acadia Healthcare during the 3rd quarter valued at approximately $86,000. Finally, Assetmark Inc. increased its stake in shares of Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company's stock worth $94,000 after acquiring an additional 591 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.